ASX
Neuren Pharmaceuticals
NEU:ASX•Healthcare
Sensitive ASX Announcement
DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024
Published: 07/08/25, 09:51am (AEST)•3 pages